These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16871773)

  • 1. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease.
    Fivenson DP
    Cutis; 2006 Jan; 77(1 Suppl):5-10. PubMed ID: 16871773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review.
    Niren NM
    Cutis; 2006 Jan; 77(1 Suppl):11-6. PubMed ID: 16871774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
    Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
    J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acne vulgaris effects of chlorogenic acid by anti-inflammatory activity and lipogenesis inhibition.
    Luo J; He W; Li X; Ji X; Liu J
    Exp Dermatol; 2021 Jun; 30(6):865-871. PubMed ID: 33433016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
    Popovic S; Urbán E; Lukic M; Conlon JM
    Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ
    Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acne vulgaris and free fatty acids. A review and criticism.
    Voss JG
    Arch Dermatol; 1974 Jun; 109(6):894-8. PubMed ID: 4275329
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.
    Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH
    J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.
    Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris.
    Seaton ED; Mouser PE; Charakida A; Alam S; Seldon PM; Chu AC
    Br J Dermatol; 2006 Oct; 155(4):748-55. PubMed ID: 16965424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral zinc administration on sebum free fatty acids in acne vulgaris.
    Rebello T; Atherton DJ; Holden C
    Acta Derm Venereol; 1986; 66(4):305-10. PubMed ID: 2430400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
    Leyden JJ; Del Rosso JQ; Webster GF
    Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nicotinamide in acne treatment.
    Walocko FM; Eber AE; Keri JE; Al-Harbi MA; Nouri K
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28220628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin barrier and microbiome in acne.
    Rocha MA; Bagatin E
    Arch Dermatol Res; 2018 Apr; 310(3):181-185. PubMed ID: 29147769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.
    Bellew S; Thiboutot D; Del Rosso JQ
    J Drugs Dermatol; 2011 Jun; 10(6):582-5. PubMed ID: 21637898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.
    Iinuma K; Sato T; Akimoto N; Noguchi N; Sasatsu M; Nishijima S; Kurokawa I; Ito A
    J Invest Dermatol; 2009 Sep; 129(9):2113-9. PubMed ID: 19282842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.